Characterization of the weak estrogen receptor α agonistic activity of exemestane
- 3 August 2008
- journal article
- research article
- Published by Springer Nature in Breast Cancer Research and Treatment
- Vol. 116 (3) , 461-470
- https://doi.org/10.1007/s10549-008-0151-x
Abstract
No abstract availableKeywords
This publication has 43 references indexed in Scilit:
- The Role of Amphiregulin in Exemestane-Resistant Breast Cancer Cells: Evidence of an Autocrine LoopCancer Research, 2008
- New experimental models for aromatase inhibitor resistanceThe Journal of Steroid Biochemistry and Molecular Biology, 2007
- Effects of steroidal and nonsteroidal aromatase inhibitors on markers of bone turnover in healthy postmenopausal womenBreast Cancer Research, 2007
- Skeletal effects of exemestane on bone-mineral density, bone biomarkers, and fracture incidence in postmenopausal women with early breast cancer participating in the Intergroup Exemestane Study (IES): a randomised controlled studyThe Lancet Oncology, 2007
- What do we know about the mechanisms of aromatase inhibitor resistance?The Journal of Steroid Biochemistry and Molecular Biology, 2006
- Aromatase Inhibitors and Bone Health in Women With Breast CancerJournal of Clinical Oncology, 2006
- Growth inhibition of estrogen receptor-positive and aromatase-positive human breast cancer cells in monolayer and spheroid cultures by letrozole, anastrozole, and tamoxifenThe Journal of Steroid Biochemistry and Molecular Biology, 2005
- Effects of the Steroidal Aromatase Inhibitor Exemestane and the Nonsteroidal Aromatase Inhibitor Letrozole on Bone and Lipid Metabolism in Ovariectomized RatsClinical Cancer Research, 2004
- A Randomized Trial of Exemestane after Two to Three Years of Tamoxifen Therapy in Postmenopausal Women with Primary Breast CancerNew England Journal of Medicine, 2004
- A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye bindingAnalytical Biochemistry, 1976